Clinical and Laboratory Rationale for Lymphotropic Defededematic Therapy in Comprehensive Treatment of Patients with Craniobrain Injury and Hemorrhagic Stroke

Abstract

Eshonov Olim Shoyimkulovich

Introductions: The effectiveness of lymphotropic decongestant therapy in patients with traumatic brain injury and hemorrhagic stroke was studied. Based on the obtained clinical and laboratory data, the effectiveness of lymphotropic decongestant therapy was revealed, which prevents the progression of cerebral edema in this category of patients.

Purpose of the Study: evaluate the effectiveness of lymphotropic decongestant therapy for cerebral edema in patients with severe TBI and hemorrhagic stroke.

Materials and Methods: The scientific study included data from patients who were in the neuroreanimation department of the Bukhara branch of the Russian Research Center for Emergency Medicine. The materials of 75 patients were studied, of which 38 with TBI and 37 patients with HI. The age of the patients ranged from 37 to 68 years (mean age was 58.2±2 years). By gender - there were 43 men (57.3%), women - 32 (42.7%). All patients underwent standard diagnostic methods (assessment of neurological status during a joint examination by a neurologist and neurosurgeon, Multislice-Computed Tomography (MSCT), as well as laboratory tests (leukoformula, neutrophil to lymphocyte ratio index (NLRI)).

PDF